|
⚲
|
| Keyboard |
| Mateus Fernando
✚
|
|
|---|---|
| CIK # | 0001895703 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001895703] | |
| 4 | [0001895703] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Abbott Laboratories | |
| Mateus Fernando |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Abbott Laboratories ABT
Common shares without par value
|
2023-02-28 | Tax withheld | 1,024 | $99.77 | 102,164 |
|
Abbott Laboratories ABT
Common shares without par value
|
2023-02-21 | Tax withheld | 664 | $106.74 | 70,875 |
|
Abbott Laboratories ABT
Common shares without par value
|
2023-02-19 | Tax withheld | 518 | $106.74 | 55,291 |
|
Abbott Laboratories ABT
Option (right to buy) · derivative
|
2023-02-17 | Grant | 41,648 | $0.00 | |
|
Abbott Laboratories ABT
Common shares without par value
|
2023-02-17 | Grant | 10,560 | $0.00 | |
|
Abbott Laboratories ABT
Common shares without par value
|
2022-07-26 | Sell | 2,457 | $109.05 | 267,936 |
|
Abbott Laboratories ABT
Common shares without par value
|
2022-02-22 | Tax withheld | 886 | $116.79 | 103,476 |
|
Abbott Laboratories ABT
Common shares without par value
|
2022-02-21 | Tax withheld | 701 | $116.79 | 81,870 |
|
Abbott Laboratories ABT
Common shares without par value
|
2022-02-19 | Tax withheld | 595 | $116.79 | 69,490 |
|
Abbott Laboratories ABT
Common shares without par value
|
2022-02-18 | Grant | 10,482 | $0.00 | |
|
Abbott Laboratories ABT
Option (right to buy) · derivative
|
2022-02-18 | Grant | 48,852 | $0.00 |